ZIVO Zivo Bioscience 8-K2021Zivo Bioscience Names Keith R. Marchiando As Chief Financial Officer
7 Jan 21
Files
SEC
- 8-K Current report
- 10.1 Exhibit 10.1 Letter Agreement Between Keith Marchiando and ZIVO Bioscience, Inc., Dated January 1, 2021
- 10.2 Exhibit 10.2 Transition and Release Agreement Between Philip Rice and ZIVO Bioscience, Inc., Dated January 7, 2021
- 99.1 Zivo Bioscience Names Keith R. Marchiando As Chief Financial Officer
Content Analysis
?
| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
|
|
ZIVO 8-K Filings
Filing View
Search this filing
Table of Contents
Get all this for free
- Email alerts for new filings that match keywords or companies
- Plot, compare & download financial data
- 10-K & 10-Q redlined comparisons
- Advanced filing search & analysis
- Sentiment analysis for financial filings
- Favorites, search history, and more…